|
"ko bs"的相關文件
顯示項目 56-63 / 63 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2008-01 |
Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan
|
Wu, SJ; Chen, CY; Su, IJ; Tang, JL; Chou, WC; Ko, BS; Huang, SY; Yao, M; Tsay, W; Chen, YC; Wang, CH; Tien, HF |
| 國立臺灣大學 |
2007-07 |
Lymph nodes in gastrointestinal tract.
|
Lee, TC; Ko, BS; Shun, CT; Lin, JT; Wang, HP |
| 國立臺灣大學 |
2007-06 |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome
|
Chen, CY; Lin, LI; Tang, JL; Tsay, W; Chang, HH; Yeh, YC; Huang, CF; Chiou, RJ; Yao, M; Ko, BS; Chen, YC; Lin, KH; Lin, DT; Tien, HF. |
| 國家衛生研究院 |
2007 |
Cyclooxygenase-2-derived prostaglandin E-2 protects mouse embryonic stem cells from apoptosis
|
Liou, JY; Ellent, DP; Lee, S; Goldsby, J; Ko, BS; Matijevic, N; Huang, JC; Wu, KK |
| 國立臺灣大學 |
2005-12 |
Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking.
|
Huang, DM; Hung, Y; Ko, BS; Hsu, SC; Chen, WH; Chien, CL; Tsai, CP; Kuo, CT; Kang, JC; Yang, CS; Mou, CY; Chen, YC |
| 國家衛生研究院 |
2005-10 |
Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking
|
Huang, DM; Hung, Y; Ko, BS; Hsu, SC; Chen, WH; Chien, CL; Tsai, CP; Kuo, CT; Kang, JC; Yang, CS; Mou, CY; Chen, YC |
| 國家衛生研究院 |
2005-01 |
Isolation of multipotent cells from human term placenta
|
Yen, BL; Huang, HI; Chien, CC; Jui, HY; Ko, BS; Yao, M; Shun, CT; Yen, ML; Lee, MC; Chen, YC |
| 國立臺灣大學 |
2005-01 |
Isolation of multipotent cells from human term placenta
|
Yen, BL; Huang, HI; Chien, CC; Jui, HY; Ko, BS; Yao, M; Shun, CT; Yen, ML; Lee, MC; Chen, YC |
顯示項目 56-63 / 63 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
|
